Literature DB >> 17223862

Effects of high-affinity nerve growth factor receptor inhibitors on symptoms in the NC/Nga mouse atopic dermatitis model.

N Takano1, T Sakurai, Y Ohashi, M Kurachi.   

Abstract

BACKGROUND: Nerve growth factor (NGF) is an important substance in the skin, where it modulates nerve maintenance and repair. However, the direct link between NGF and pruritic diseases such as atopic dermatitis is not yet fully understood. Our previous study showed that NGF plays an important role in the pathogenesis of atopic dermatitis-like skin lesions in NC/Nga mice. NGF mediates its effects by binding to two classes of transmembrane receptors, a high-affinity receptor (tropomyosin-related kinase A, TrkA) and a low-affinity receptor (p75).
OBJECTIVES: To determine the significance of NGF receptors in the pathogenesis of atopic dermatitis, the effects of TrkA inhibitors AG879 and K252a on the symptoms of NC/Nga mice were evaluated.
METHODS: Male NC/Nga mice with severe skin lesions were used. AG879 or K252a was applied to the rostral part of the back of mice five times a week. The dermatitis score for the rostral back was assessed once a week. The scratching behaviour was measured using an apparatus, MicroAct (Neuroscience, Tokyo, Japan). Immunofluorescence examinations were made in the rostral back skin for nerve fibres, NGF and TrkA receptor.
RESULTS: Repeated applications of AG879 or K252a significantly improved the established dermatitis and scratching behaviour, and decreased nerve fibres in the epidermis. NGF was observed more weakly in keratinocytes, and a lower expression of TrkA was observed in stratum germinativum of the epidermis of mice treated with AG879 or K252a compared with those treated with vehicle.
CONCLUSIONS: We suggest that NGF plays an important role in the pathogenesis of atopic dermatitis-like skin lesions via the high-affinity NGF receptor. These findings provide a new potential therapeutic approach for the amelioration of symptoms of atopic dermatitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17223862     DOI: 10.1111/j.1365-2133.2006.07636.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  9 in total

Review 1.  Atopic dermatitis and the nervous system.

Authors:  Laurent Misery
Journal:  Clin Rev Allergy Immunol       Date:  2011-12       Impact factor: 8.667

Review 2.  Targeted treatment of pruritus: a look into the future.

Authors:  H L Tey; G Yosipovitch
Journal:  Br J Dermatol       Date:  2011-05-30       Impact factor: 9.302

Review 3.  The itchy scalp--scratching for an explanation.

Authors:  Ghada A Bin Saif; Marna E Ericson; Gil Yosipovitch
Journal:  Exp Dermatol       Date:  2011-12       Impact factor: 3.960

4.  A study of serum concentrations and dermal levels of NGF in atopic dermatitis and healthy subjects.

Authors:  Alexandru D P Papoiu; Hui Wang; Leigh Nattkemper; Hong Liang Tey; Yozo Ishiuji; Yiong-Huak Chan; Martin Schmelz; Gil Yosipovitch
Journal:  Neuropeptides       Date:  2011-09-03       Impact factor: 3.286

5.  The excimer lamp induces cutaneous nerve degeneration and reduces scratching in a dry-skin mouse model.

Authors:  Atsuko Kamo; Mitsutoshi Tominaga; Yayoi Kamata; Kazuyuki Kaneda; Kyi C Ko; Hironori Matsuda; Utako Kimura; Hideoki Ogawa; Kenji Takamori
Journal:  J Invest Dermatol       Date:  2014-06-18       Impact factor: 8.551

Review 6.  Skin neurogenic inflammation.

Authors:  Jae Eun Choi; Anna Di Nardo
Journal:  Semin Immunopathol       Date:  2018-04-30       Impact factor: 9.623

Review 7.  Sleep Disturbances and Atopic Dermatitis: Relationships, Methods for Assessment, and Therapies.

Authors:  Fatima Bawany; Carrie A Northcott; Lisa A Beck; Wilfred R Pigeon
Journal:  J Allergy Clin Immunol Pract       Date:  2020-12-13

8.  GPR15L is an epithelial inflammation-derived pruritogen.

Authors:  Pang-Yen Tseng; Mark A Hoon
Journal:  Sci Adv       Date:  2022-06-15       Impact factor: 14.957

Review 9.  Atopic dermatitis: allergic dermatitis or neuroimmune dermatitis?

Authors:  Neide Kalil Gaspar; Márcia Kalil Aidé
Journal:  An Bras Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.896

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.